Education
About Us
Working with TipRanks
Follow Us
Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -1.41M |
| Operating Income | $ -569.55M | $ -468.04M | $ -232.26M | $ -103.67M | $ -89.58M |
| EBITDA | $ -448.08M | $ -392.10M | $ -214.03M | $ -96.61M | $ -87.81M |
| Net Income | $ -463.93M | $ -402.27M | $ -223.49M | $ -100.08M | $ -89.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.75B | $ 1.08B | $ 931.38M | $ 245.97M | $ 386.20M |
| Total Assets | $ 3.51B | $ 1.41B | $ 1.01B | $ 324.34M | $ 392.83M |
| Total Debt | $ 71.11M | $ 29.22M | $ 17.94M | $ 16.78M | $ 0.00 |
| Net Debt | $ -316.77M | $ -368.23M | $ -816.72M | $ -52.20M | $ -386.20M |
| Total Liabilities | $ 205.50M | $ 167.45M | $ 52.56M | $ 40.32M | $ 46.98M |
| Stockholders' Equity | $ 3.31B | $ 1.24B | $ 953.61M | $ 284.02M | $ 345.84M |
| Cash Flow | |||||
| Free Cash Flow | $ -475.05M | $ -364.67M | $ -176.44M | $ -127.95M | $ -47.78M |
| Operating Cash Flow | $ -452.63M | $ -296.79M | $ -170.60M | $ -121.39M | $ -46.63M |
| Investing Cash Flow | $ -2.01B | $ -773.31M | $ 74.58M | $ -212.31M | $ -1.10M |
| Financing Cash Flow | $ 2.45B | $ 639.81M | $ 861.55M | $ 17.80M | $ 374.87M |